Selank

Also known as: TP-7

Selank is a synthetic heptapeptide derived from the immunomodulatory peptide tuftsin, developed originally at the Institute of Molecular Genetics (Russian Academy of Sciences).

Research context

Selank is a synthetic heptapeptide derived from the immunomodulatory peptide tuftsin, developed originally at the Institute of Molecular Genetics (Russian Academy of Sciences). Preclinical work investigates effects on GABAergic and monoaminergic systems in rodent anxiety and cognition models.

Storage & stability

Store lyophilized at -20°C.

Purity & testing standards

Each batch of Selank is analyzed by an independent third-party laboratory. Standard release testing includes reverse-phase HPLC at 220 nm (purity target HPLC ≥99%), electrospray mass spectrometry (identity confirmation), and endotoxin screening. Batch numbers on each vial resolve to a downloadable COA on this site.